Just got word from my Oncology Office that my trial has been "unblinded" and that I indeed am in Arm 3.
Arm 3: Avastin in combination with carboplatin and paclitaxel chemotherapy followed by the maintenance use of Avastin alone, for a total of up to 15 months of therapy.
The study showed that women who continued maintenance use of Avastin alone, after receiving Avastin in combination with chemotherapy (Arm 3), lived longer without the disease worsening compared to those who received chemotherapy alone.
About Me
Subscribe to:
Post Comments (Atom)
I was "unblinded" by science! ;~)
ReplyDeleteThat's good to hear Cheri, glad things keep sounding better and better.